Featured Insights
April 29, 2026
Blog
EPA’s decision, paired with a newly unveiled research program from the Department of Health and Human Services, increases scrutiny on these emerging contaminants.
April 29, 2026
Newsletter
A quarterly update for US public companies from the Public Company Representation Practice.
April 28, 2026
Client Alert
The executive order and agency actions reflect shift to prioritize regulatory review, expand patient access, and fund research into psychedelic drugs.